Literature DB >> 17707367

9-Benzylidene-naphtho[2,3-b]thiophen-4-ones and benzylidene-9(10H)-anthracenones as novel tubulin interacting agents with high apoptosis-inducing activity.

Anne Zuse1, Helge Prinz, Klaus Müller, Peter Schmidt, Eckhard G Günther, Frank Schweizer, Jochen H M Prehn, Marek Los.   

Abstract

Tubulin-binding 9-benzylidene-naphtho[2,3-b]thiophen-4-ones 1a and 1b and benzylidene-9(10H)-anthracenone 2 were evaluated for their ability to induce cell death. We examined the effect of the molecules on cell cycle progression, organization of microtubule networks, and apoptosis induction. As determined by flow cytometry, cancer cells were predominantly arrested in metaphase with 4N DNA before cell death occurred. By using indirect immunofluorescence techniques we visualized microtubule depolymerization recognizable by short microtubule fragments scattered around the nucleus. The incubation with 1a and 2 resulted in chromatin condensation, nuclear fragmentation, and cell shrinkage, which are, among others, typical features of apoptotic cell death. Furthermore, time- and dose-dependent induction of apoptosis in SH-SY5Y cells was detected via cleavage of Ac-DEVD-AMC, a fluorigenic substrate for caspase-3. We observed a lower apoptotic activity in neuroblastoma cells overexpressing Bcl-xL, suggesting activation of the mitochondrial apoptosis pathway. Western blot analysis demonstrated that caspase-3, an apoptosis mediator, was activated in a time-dependent manner after exposure of SH-SY5Y cells to drugs 1a and 2. Taken together, the agents investigated in the present study display strong apoptosis-inducing activity and therefore show promise for the development of novel chemotherapeutics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17707367     DOI: 10.1016/j.ejphar.2007.07.050

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

Review 1.  Adult stem cells and their trans-differentiation potential--perspectives and therapeutic applications.

Authors:  Sabine Hombach-Klonisch; Soumya Panigrahi; Iran Rashedi; Anja Seifert; Esteban Alberti; Paola Pocar; Maciej Kurpisz; Klaus Schulze-Osthoff; Andrzej Mackiewicz; Marek Los
Journal:  J Mol Med (Berl)       Date:  2008-07-16       Impact factor: 4.599

Review 2.  Cancer stem cells as targets for cancer therapy: selected cancers as examples.

Authors:  Sabine Hombach-Klonisch; Ted Paranjothy; Emilia Wiechec; Paola Pocar; Tarek Mustafa; Anja Seifert; Christian Zahl; Klaus Luis Gerlach; Katharina Biermann; Klaus Steger; Cuong Hoang-Vu; Klaus Schulze-Osthoff; Marek Los
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-05-30       Impact factor: 4.291

3.  In vivo manganese exposure modulates Erk, Akt and Darpp-32 in the striatum of developing rats, and impairs their motor function.

Authors:  Fabiano M Cordova; Aderbal S Aguiar; Tanara V Peres; Mark W Lopes; Filipe M Gonçalves; Aline P Remor; Samantha C Lopes; Célso Pilati; Alexandra S Latini; Rui D S Prediger; Keith M Erikson; Michael Aschner; Rodrigo B Leal
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

4.  Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway.

Authors:  Saeid Ghavami; Ahmad Asoodeh; Thomas Klonisch; Andrew J Halayko; Kamran Kadkhoda; Tadeusz J Kroczak; Spencer B Gibson; Evan P Booy; Hossein Naderi-Manesh; Marek Los
Journal:  J Cell Mol Med       Date:  2008-06       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.